ubs glp-1 sales forecast Antagonists Increase Plan Drug Spend - What's Next GLP-1 Market Size to Hit

To lower the risk of major cardiovascular problems (such as heart attack or stroke) in adults with obesity or overweight and known heart disease

This makes a big difference for anyone squeamish about needles or who just wants a diabetes pill, no needles option

Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64

When combined with a healthy diet and regular exercise program, compounded GLP-1 therapy has been shown to help men and women lose weight and attain a healthier lifestyle

They don't deserve it

Estrogenic activity of standardized extract of Angelica sinensis